This quarterly report and other reports filed by Cannabis Suisse Corp. (Formerly Geant Corp.) ("we," "us," "our," or the "Company"), from time to time contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company's management as well as estimates and assumptions made by Company's management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the filings, the words "anticipate", "believe", "estimate", "expect", "future", "intend", "plan" or the negative of these terms and similar expressions as they relate to the Company or the Company's management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States ("GAAP"). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

In General

We were incorporated in the State of Nevada on February 26, 2016. Our initial business direction was production of paper made from elephant dung for making different stationery products and distributing them mainly in Sri Lanka. The Company ceased the mentioned operations on March 1, 2020.

On February 20, 2019, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State for changing the Company's name from 'Geant Corp.' to 'Cannabis Suisse Corp.

The Company is engaged in distribution of CBD Oils in the U.S. market using online means.

We have never declared bankruptcy, have never been in receivership, and have never been involved in any legal action or proceedings.

Our business office is located at Lerzenstrasse 12, 8953 Dietikon, Switzerland. The Board of Directors considers the said premises appropriate for the business direction the Company is following. Our telephone number is +15022082098.

Product Overview

The main business of the Company is distribution of cannabis and the related products. They are laboratory tested to ensure the end-users have access to a standardized, safe, and consistent product. Cannabis Suisse Corp. sells online under the retail brand Swiss4Life.

Swiss4Life concept is based on the Company's mission to improve the quality of life of its customers by providing them with high-grade CBD products. At this stage Cannabis Suisse Corp. offers following products:

1)

The Swiss4Life first product comes in one fluid ounce (30ml) available in two flavors: Crème de Menthe and Cherry Vanilla. It is a Broad Spectrum Oil with CBD concentrations of 1500 mg, 2500 mg, 3500 mg.

2)

Swiss4Life TerpX2 is one fluid ounce (30ml). It is a CBD tincture with 1000mg CBD concentrations per bottle and 33.33 mg CBD per serving. The product contains 0% THC, which means it will effectively perform therapeutic functions without causing adverse reactions. High quality hemp seed oil is the carrier in the new product saving all the important nutrients, including protein, vitamins, fatty acids and minerals. Omega 3-6-9 is a complex of the most important unsaturated fatty acids for human health.







                                       18


3)

Swiss4Life TerpX3 is a one fluid ounce (30ml) CBD tincture with 1000mg CBD concentrations per bottle and 33.33 mg CBD per serving. Swiss4Life TerpX3 will contain 0% THC, which means it will effectively perform therapeutic functions without causing adverse reactions.

4)

Swiss4Life TerpX5 is one fluid ounce (30ml). It will be CBD tincture with 1000mg CBD concentrations per bottle and 33.33 mg CBD per serving. All of the oil products will include graduated droppers for accurate dosing, so consumers will have the ability to choose the dosage that best suits them personally. Natural Sleep Formula in Swiss4Life TerpX5 composition will provide anti-stress and sedative effects without losses in concentration level during the day and will help you to improve your natural sleep during the night. Swiss4Life TerpX5 may help you get rid of insomnia, staying focused, and being full of energy.

Market background

Cannabis users from California, Colorado, Arizona, Oregon, and Washington spend around $36 million in pre-rolled joints monthly according to the report introduced by BDS Analytics.

Some European countries like Germany, Denmark, Malta, Greece, and Italy discussed the possibility of creating a completely regulated cannabis market by 2028. Furthermore, Luxembourg intends to introduce a regulated market for adult use of cannabis by 2023.

The research conducted by the Brightfield Group, and based on impending regulatory changes in EU, indicates that the European CBD market is expected to be worth $1.7 billion by 2023. The cannabis market in general is also set to experience rapid growth, from $318 million in 2018 to nearly $8 billion by 2023.

Competition

We acknowledge the market of CBD-related items is rather competitive. There are several companies that offer comparative items and we have to compete with them. We see the main competitive advantage of our competitors is the established customer base and marketing outlets. Nevertheless, we arrange on a wholesale exchange, for the most part, so we have capacity to offer our items for extensive organizations in huge amounts. Therefore, we believe our item is more extensive, the quality is better, and our ways to deal with business are more flexible.




Marketing

We use marketing strategies such as web advertisements, press releases, direct mailing, and phone calls to acquire potential customers. We attract traffic to our website by a variety of online marketing tactics, such as registering with top search engines, using selected key words and meta-tags, and utilizing link and banner exchange options.

The website related to cannabis cultivation is https://www.cannabissuisse.com. The growing process is streamed online on this website. Also, it includes the information about the main Company's products, our team and our plans for further development.

We will intend to continue our marketing efforts during the life of our operations. There is no guarantee that we will be able to attract and more importantly retain enough customers to justify our expenditures. If we are unable to generate a significant amount of revenue and to successfully protect ourselves against those risks, then it would materially affect our financial condition and our business could be harmed.

Description of property

Our chief executive officer, Suneetha Nandana Silva Sudusinghe, has agreed to provide us his own premises at no charge. He will not take any fee for these premises. This premise is used for production of the goods. The Company has discontinued using the mentioned office space on March 1, 2020.

On September 28, 2016 the Company executed a Rent office agreement, beginning on January 1, 2017, terminated on January 1, 2018 which was extended through December 31, 2019. These premises will be used as a representative office for the customers. The rent payment is $120 per month. This Rent office agreement was terminated on March 1, 2020.







                                       19

On April 18, 2017, the Company signed a Rent office agreement, beginning on June 1, 2017 which will terminate on May 31, 2022. These premises will be used as a representative office for the customers of Grow Factory GmbH. The rent payment is $6,646 per month. For the six months ended November 30, 2020, we have $38,397 of rent expense. The rent office agreement was not effective as of November 30, 2020. On November 23, 2020, Cannabis Suisse Corp. transferred all the assets to Cannabis Suisse LLC.

Research and Development Expenditures

We have not incurred any research expenditures since our incorporation.

Bankruptcy or Similar Proceedings

There has been no bankruptcy, receivership or similar proceeding.

Results of Operations for the three and six months ended November 30, 2020 and 2019:

Revenue and Cost of Goods Sold

For the three months ended November 30, 2019, the Company generated total revenue of $47,190 from selling products to the customer. The cost of goods sold for the three months ended November 30, 2019 was $94,585, which represent the cost of raw materials.

For the six months ended November 30, 2019, the Company generated total revenue of $106,442 from selling products to the customer. The cost of goods sold for the six months ended November 30, 2019 was $200,555, which represent the cost of raw materials.

For the three months ended November 30, 2020, the Company has generated total revenue of $11,226 from selling products to the customer. The cost of goods sold for the three months ended November 30, 2020 was $28,841.

For the six months ended November 30, 2020, the Company generated total revenue of $50,850 from selling products to the customer. The cost of goods sold for the six months ended November 30, 2020 was $102,648.

The Company's revenues consist of the sale of goods from principal activity and secondary activity. The sale of goods from principal activity includes the sale of CBD products. The sale of goods from secondary activity includes the sale of face masks and disinfectants.

The decrease in revenues and cost of goods sold is a result of separating of Cannabis Suisse LLC in November 2020.

Operating expenses

Total operating expenses for the three months ended November 30, 2019, were $96,271. The operating expenses for the three months ended November 30, 2019, included professional fees of $28,579; depreciation expense of $7,643; and general and administrative expenses of $60,049.

Total operating expenses for the three months ended November 30, 2020, were $75,850. The operating expenses for the three months ended November 30, 2020, included professional fees of $12,000; depreciation expense of $4,163; and general and administrative expenses of $59,687.

Total operating expenses for the six months ended November 30, 2019, were $177,844. The operating expenses for the six months ended November 30, 2019, included professional fees of $46,355; depreciation expense of $8,322; and general and administrative expenses of $123,167.

Total operating expenses for the six months ended November 30, 2020, were $206,171. The operating expenses for the six months ended November 30, 2020, included professional fees of $33,896; depreciation expense of $8,324; and general and administrative expenses of $163,951.

The change in operating expenses is related to the reduction of growing plants.



                                       20





Net Loss

The net loss for the three months ended November 30, 2020 and 2019 was $93,465 and $143,666, respectively.

The net loss for the six months ended November 30, 2020 and 2019 was $257,969 and $271,957, respectively.

Liquidity and Capital Resources and Cash Requirements

As of November 30, 2020, the Company had cash of $0. Furthermore, the Company had a working capital deficit of $124,619.

During the six months ended November 30, 2020 and 2019 the Company used $83,068 and $188,306 of cash in operating activities respectively. The change in cash used in operating activities is related to the decrease in net income, depreciation, accounts receivable, accrued wages, and advances from customers and the reduction in accounts payable, accrued expenses, and VAT tax receivable.

During the six months ended November 30, 2020 and 2019 the Company had $0 of cash in investing activities.

During the six months ended November 30, 2020 and 2019 the Company was provided $83,063 and $130,996 of cash in financing activities respectively, which came from advances from related parties and bank indebtedness.

In its audited consolidated financial statements as of May 31, 2020, the Company was issued a "going concern" opinion, meaning that there is substantial doubt we can continue as an on-going business for the next twelve months unless we obtain additional capital. Our only sources for cash at this time are investments by others, selling our products and loans from our director. We must raise cash to implement our plan and stay in business.

Management believes that current trends toward lower capital investment in start-up companies pose the most significant challenge to the Company's success over the next year and in future years. Additionally, the Company will have to meet all the financial disclosure and reporting requirements associated with being a public reporting company. The Company's management will have to spend additional time on policies and procedures to make sure it is compliant with various regulatory requirements, especially that of Section 404 of the Sarbanes-Oxley Act of 2002. This additional corporate governance time required of management could limit the amount of time management has to implement is business plan and impede the speed of its operations.

Limited operating history; need for additional capital

There is no historical financial information about us upon which to base an evaluation of our performance. We are in a start-up stage of operations and have generated limited revenues since inception. We cannot guarantee that we will be successful in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible cost overruns due to price and cost increases in services and products.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Related Party Transactions

There are two signed loan agreements between Cannabis Suisse Corp. and the President/CEO and a Director of the Company, Suneetha Nandana Silva Sudusinghe. The CEO agreed to loan the Loan Amount to the Company in the event of not raising sufficient amount of funds from the offering in accordance to the Form S-1 registration statement of the Company; the director agreed to loan the Loan Amount to the Company on demand of the Company; the Company will conduct the repayments of all amounts of the Director's loan accordingly to the sequence of loans; the director will be repaid from revenues of the Company, when it starts to earn significant revenues; advanced Loan funds are non-interest bearing, secured and payable upon demand.




                                       21





Critical Accounting Policies

The preparation of financial statements in accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A change in managements' estimates or assumptions could have a material impact on our financial condition and results of operations during the period in which such changes occurred. Actual results could differ from those estimates. Our financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented.

© Edgar Online, source Glimpses